Key result
Continuous superficial parasternal intercostal plane (SPIP) blockade does not currently demonstrate clinically meaningful incremental improvements over single-injection blockade to justify its routine use in cardiac surgery.
Why the study?
Does continuous SPIP blockade improve outcomes compared to single-injection SPIP blockade in patients undergoing cardiac surgery?
Does continuous SPIP blockade improve outcomes compared to single-injection SPIP blockade in patients undergoing cardiac surgery?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“EPOCH CardioLink-10 was designed to determine whether a pragmatic, catheter-based SPIP regimen reduces postoperative opioid exposure versus placebo, not to isolate bolus versus catheter-dosing contributions, nor establish superiority over single-injection technique. Our findings should not be interpreted as a direct continuous-versus-single-injection comparison; equally, that absence does not support a preference for single-injection blockade.”
“Modern-day cardiac surgery was originally made possible with the use of high-dose morphine-based anesthesia that provided stable heart function and blood pressure and allowed surgeons to do the kinds of surgery they needed to do.”
Single-injection SPIP blockade should remain the preferred technique for median sternotomy until continuous blockade shows clear patient-centered benefits that outweigh the risks.
We congratulate Alli et al. on their multicentre trial, demonstrating that superficial parasternal intercostal plane (SPIP) blockade, compared with sham blockade, significantly reduced 72-h opioid consumption after median sternotomy.1 These findings reinforce prior literature supporting SPIP blockade in cardiac surgery,2 and we agree SPIP blockade should be incorporated into enhanced recovery after cardiac surgery pathways. However, the optimal choice between single-injection and continuous blockade remains uncertain.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2026) conducted a letter in Cardiac surgery. Continuous superficial parasternal intercostal plane (SPIP) blockade vs. Single-injection SPIP blockade was evaluated. Continuous superficial parasternal intercostal plane (SPIP) blockade does not currently demonstrate clinically meaningful incremental improvements over single-injection blockade to justify its routine use in cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: